Big Pharma Dangles Life and Death Over Patients’ Heads

‘Gene therapy involves identifying and replacing faulty or missing genes, or engineering augmentations for existing genes to permanently cure a wide number of conditions and illnesses ranging from cancer and diabetes, to regenerative processes like rebuilding hearts or storing sight and hearing.

A breakthrough clinical trial in 2012 saw several patients stricken with incurable leukemia put into permanent remission using gene therapy. The actual process of creating re-engineered cells taken from a patient and reintroducing them costs approximately $15,000, and such procedures are still in the experimental phase. While this cost does not include the required intensive care required to bring a patient from the brink of death back into full health, it is likely the costs in the near future will be drastically lower than current and far less effective cancer treatments are today.’

Read more: Big Pharma Dangles Life and Death Over Patients' Heads